A Study of Antimicrobial Resistance in Clinical Isolates of Enterococci
A Study of Antimicrobial Resistance in Clinical Isolates of Enterococci
DOI:
https://doi.org/10.70284/njirm.v5i6.835Keywords:
Enterococcus, Antibiotic resistance, MICAbstract
Introduction: Recent years have witnessed a resurgence of interest in enterococci due to increasing resistance to antibiotics in term of both multiplicity of resistance and level of resistance to particular drugs. Methodology: This is a hospital based study, conducted in R.D. Gardi Medical College and C.R.G.Hospital Ujjain (M.P.). All clinical samples such as urine, blood, pus, sputum, ascitic fluid, stool etc. were collected from patients visiting OPD and admitted in CRGH in the study period of 1 and 1/2 year (January 2011-June 2012). Bacterial colonies suggestive of enterococci were further identified and antibiotic susceptibility testing done for each enterococcal isolates by DDT of Kirby Bauer on Muller Hinton Agar according to CLSI guideline.3,5,6 MIC was also determine for ampicillin, gentamicin, streptomycin and vancomycin by Agar dilution.6 Result and Observation: Only 2 enterococcal species isolated they were E.faecalis (86.62%) and E.faecium (15.18%). In pathogenic E.faecalis, 90.28% isolates showed resistance to penicillin, 65.28% to ampicillin, 62.5% to high level gentamicin (HLG) and 51.39% to high level streptomycin (HLS). One E.faecalis was resistant to vancomycin (VRE). All E.faecalis were sensitive to linezolid. In pathogenic E.faecium 84.61% isolates showed resistance to penicillin, 23.08 % to ampicillin, 53.85% to HLG and 69.23% to HLS. All E.faecium were sensitive to vancomycin and linezolid. In colonizing enterococci resistance is very low as compared with pathogenic. Multiple drug resistance (penicillinG, ampicillin, HLG, HLS) was more common (32.94%) in isolates of enterococci. Discussion: Study from Sevagram and Nagpur also isolated two species of Enterococci. Very high penicillin-G resistance was also observed in study from Nagpur.15 In this study resistance to ampicillin in E.faecalis was 65.28% and in E.faecium 23.08%. A study done in Mumbai also find similar finding.16 A study done by Rahangdale et al, which showed 49.59% high level resistance to gentamicin.15 In this study HLSR in E.faecalis was 51.39% and in E.faecium 69.23%. Observation close to our study was reported from Nagpur.15 Vancomycin resistance was not detected in E.faecium. Resistance to vancomycin is widely variable. Agrarwal et al, Titze-de-Almeida et al, Rahangdale et al, did not get any VRE in their study. 14,15,17 Conclusion: Multidrug resistances are the common problem. Although, at present, VRE is not a problem in our set up, its routine monitoring is essential, since it appears to be an emerging pathogen in India.13 [Jain S NJIRM 2014; 5(6):81-87]
References
2. Moellering RC, Jr. Emergence of Enterococcus as a significant pathogens Clin Infect Dis 1992;14:1173-1178.
3. Color Atlas and textbook of Microbiology by Koneman. 5th edition page 597-599.
4. Edmond MB, Ober JF, Dawson JD, Weinbaum DL, Wenzel RP. Vancomycin-resistant Enterococcal bacteremia: natural history and attributable mortality. Clin Infect Dis 1996;23:1234-9.
5. Bauer AW, Kirby WM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966 Apr;45(4):493-6.
6. Clinical and Laboratory Standards Institute antimicrobial susceptibility testing standards. M100-S20, Vol. 30, No. 1, page 76-79
7. Murray BE. The life and times of the Enterococcus. Clin Microbiol Rev 1990; 3 :46-65.
8. Patterson JE, Masecar BL and Zervos MJ. Characterisation and comparison of two penicillinase producing strains of Streptococcus (Enterococcus) faecalis. Antimicrob Agents Chemother 1988;32:122-124.
9. Jesudason MV, Pratima VL, Pandian R, Abigail S. Characterization of penicillin resistant Enterococci. Indian J Med Microbiol 1998;16:8-16.
10. Bose S, Ghosh AK, Barapatre R. Prevalence Of Drug Resistance Among Enterococcus Spp Isolated From A Tertiary Care Hospital. Int J Med Health Sci. July 2012,Vol-1;Issue-3.
11. Adhikari L. High-level aminoglycoside resistance and reduced susceptibility to vancomycin in nosocomial enterococci. J Global Infect Dis 2010;2:231-235.
12. Agrawal J, Kalyan R, and Singh M. High level aminoglycoside resistance and β-lactamase production in enterococci at a tertiary care hospital in india. Jpn. J. Infect. Dis.,62, 158-159, 2009.
13. Mendiratta DK, Kaur H, Deotale V, Thamke DC, Narang R, Narang P. Status of high level aminoglycoside resistant entericoccus faecium & enterococcus faecalis in a rural hospital of central India. Indian Journal of Medical Microbiology, (2008) 26(4): 369-71
14. Agarwal VA, Jain YI, Pathak AA. Concomitant high level resistance to penicillin and aminoglycosides in enterococci at Nagpur, Central India. Indian J Med Microbiol Year : 1999 Volume : 17,Issue : 2, Page : 85-87.
15. Rahangdale VA, Agrawal G, Jalgaonkar SV. Study of antimicrobial resistance in enterococci. Indian J Med Microbiol Year : 2008, Volume : 26, Issue : 3 Page : 285-287.
16. Karmarkar MG, Gershom ES & Mehta PR. Enterococcal infections with special reference to phenotypic characterization & drug
resistance. Indian J Med Res 119 (Suppl) May 2004, pp 22-25.
17. Ricardo TA et al. Molecular Epidemiology and Antimicrobial Susceptibility of Enterococci Recovered from Brazilian Intensive Care Units. The Brazilian Journal of Infectious Diseases 2004;8(3):197-205.
18. Bekhit MMS, Moussa IMI, Muharram MM, Alanazy FK, Hefni HM. Prevalence and antimicrobial resistance pattern of multidrug-resistant enterococci isolated from clinical specimens. Indian J Med Microbiol Year : 2012 Volume : 30 Issue : 1 Page : 44-51
19. Murray BE. Vancomycin resistant enterococci. Am J Med 1997; 101 :284-93.
20. George G. Zhanel, Daryl J. Hoban, and James A. Karlowsky. Nitrofurantoin Is Active against Vancomycin-Resistant Enterococci. Antimicrobial Agents and Chemotherapy, Jan. 2001, p. 324–326).
